uniQure (NASDAQ: QURE) director sells 6,390 shares under 10b5-1 plan

Rhea-AI Filing Summary

uniQure N.V. director Jack Kaye reported an option exercise and share sale. On January 9, 2026, he exercised a stock option for 6,390 ordinary shares at an exercise price of $19.39 per share, converting the option into shares.

The same day, he sold 6,390 ordinary shares at a weighted average price of $27.28, with individual sale prices ranging from $27.19 to $27.39. These transactions were made under a Rule 10b5-1 sales plan adopted on June 16, 2025. After the sale, Kaye directly owned 20,439 ordinary shares of uniQure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaye Jack

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM P7 11058BP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/09/2026		M(1)		6,390	A	$19.39	26,829	D
Ordinary Shares	01/09/2026		S(1)		6,390	D	$27.28(2)	20,439	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$19.39	01/09/2026		M(1)			6,390	(3)	01/26/2028	Ordinary Shares	6,390	$0	0	D

Explanation of Responses:

1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Stock Option vested in full on January 26, 2019.

	/s/ Christian Klemt, Attorney-in-Fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did uniQure (QURE) director Jack Kaye report?

Jack Kaye reported exercising a stock option for 6,390 ordinary shares of uniQure N.V. and then selling 6,390 ordinary shares on January 9, 2026.

At what prices did Jack Kaye exercise and sell uniQure (QURE) shares?

He exercised a stock option at an exercise price of $19.39 per share and sold the resulting 6,390 shares at a weighted average price of $27.28, with individual trades between $27.19 and $27.39.

How many uniQure (QURE) shares does Jack Kaye own after this Form 4 filing?

Following the reported transactions, Jack Kaye directly owned 20,439 ordinary shares of uniQure N.V.

Was Jack Kaye’s sale of uniQure (QURE) shares under a Rule 10b5-1 trading plan?

Yes. The filing states the transactions were effected under a sales plan adopted on June 16, 2025 that was intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

What derivative security did Jack Kaye hold in uniQure (QURE) and what happened to it?

He held a stock option (right to buy) for 6,390 ordinary shares with an exercise price of $19.39. It was exercised in full on January 9, 2026, leaving 0 derivative securities of that option outstanding.

When did the stock option exercised by Jack Kaye in uniQure (QURE) originally vest?

The filing notes that the stock option vested in full on January 26, 2019.

What does the weighted average sale price in Jack Kaye’s uniQure (QURE) Form 4 mean?

The reported $27.28 is a weighted average sale price for multiple trades, with shares sold in a price range from $27.19 to $27.39. Detailed trade-by-trade prices are available from the reporting person upon request.